Drugs / Pegylated asparaginase
Pegylated asparaginase
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00671658 | Nov 2002 → Jul 2013 | acute lymphoblastic leukemia | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02845882 | Jan 2016 → Dec 2023 overdue | lymphoblastic lymphoma | Children's Cancer Group, China | Active not recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07443592 | Mar 2026 → Mar 2031 expected | acute lymphoblastic leukemia | PETHEMA Foundation | Not yet recruiting | No outcome recorded |
| — | NCT04179929 | Nov 2019 → Nov 2026 expected | acute lymphoblastic leukemia | PETHEMA Foundation | Recruiting | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06336395 Background | Mar 2020 → Mar 2030 expected | B-cell acute lymphoblastic leukemia | National University Hospital, Singapore | Recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05681260 Background | Feb 2023 → Dec 2026 expected | T-lymphoblastic lymphoma | Children's Cancer Group, China | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pegylated asparaginase | “Participants will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT07443592 ↗5“Patients will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT04179929 ↗ |
| Known as | PEG-asparaginase | “Totally, 3 doses of PEG-asparaginase (Pegylated-asparaginase) are applied in this group.” NCT02845882 ↗ |
| Known as | PegASP | “Participants will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT07443592 ↗1“Patients will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT04179929 ↗ |